|
Volumn 88, Issue 4, 2000, Pages 554-557
|
CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CANCER GRADING;
CANCER SURVIVAL;
CELL CYCLE;
CONTROLLED STUDY;
CPG ISLAND;
GENE CONTROL;
GENE DELETION;
GENETIC CODE;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
METHYLATION;
OLIGODENDROGLIOMA;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
BRAIN NEOPLASMS;
CELL NUCLEUS;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
DINUCLEOSIDE PHOSPHATES;
DNA METHYLATION;
GENE DELETION;
GENES, P16;
HOMOZYGOTE;
HUMANS;
OLIGODENDROGLIOMA;
PROGNOSIS;
SURVIVAL ANALYSIS;
|
EID: 0033767164
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0215(20001115)88:4<554::AID-IJC6>3.0.CO;2-Q Document Type: Article |
Times cited : (57)
|
References (28)
|